These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7964857)

  • 1. Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Kaveri SV; Mouthon L; Kazatchkine MD
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):6-8. PubMed ID: 7964857
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.
    Kazatchkine MD; Kaveri SV
    N Engl J Med; 2001 Sep; 345(10):747-55. PubMed ID: 11547745
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous immunoglobulin G in the treatment of autoimmune bullous disease.
    Czernik A
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):118-9. PubMed ID: 25546786
    [No Abstract]   [Full Text] [Related]  

  • 4. IVIG-mediated effector functions in autoimmune and inflammatory diseases.
    Galeotti C; Kaveri SV; Bayry J
    Int Immunol; 2017 Dec; 29(11):491-498. PubMed ID: 28666326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
    Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):111. PubMed ID: 25546783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation.
    Brückner C; Lehmann C; Dudziak D; Nimmerjahn F
    Int Immunol; 2017 Dec; 29(11):499-509. PubMed ID: 29300958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation of autoimmune and systemic inflammatory diseases with intravenous immunoglobulin.
    Mouthon L; Piketty C; Kazatchkine MD
    Vox Sang; 1994; 67 Suppl 3():53-9. PubMed ID: 7975512
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Ruiz de Souza V; Kaveri SV; Kazatchkine MD
    Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IVIG as a nonspecific accelerator of restitutio ad integrum.
    Rewald E
    Transfus Sci; 2000 Oct; 23(2):163-4. PubMed ID: 11035277
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous immunoglobulin and immune response.
    Kaveri SV; Lecerf M; Saha C; Kazatchkine MD; Lacroix-Desmazes S; Bayry J
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):94-6. PubMed ID: 25546777
    [No Abstract]   [Full Text] [Related]  

  • 12. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immune globulin in autoimmune and inflammatory diseases.
    Gelfand EW
    N Engl J Med; 2012 Nov; 367(21):2015-25. PubMed ID: 23171098
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulin therapy in dermatologic disorders.
    Cakmak SK; Gül U; Gönül M; Kiliç A; Soylu S
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):75-84. PubMed ID: 18691136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin: implications for use in the neurological patient.
    Chipps E; Skinner C
    J Neurosci Nurs; 1994 Feb; 26(1):8-17. PubMed ID: 8195653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous immunoglobulins (IgIV) in the treatment of autoimmune diseases and systemic inflammatory diseases].
    Kazatchkine M
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):209-10. PubMed ID: 8337128
    [No Abstract]   [Full Text] [Related]  

  • 17. Practical considerations for the use of IGIV therapy: introduction.
    Shah S
    Am J Health Syst Pharm; 2005 Aug; 62(16 Suppl 3):S3-4. PubMed ID: 16100385
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies: basic mechanisms and emerging concepts.
    Gupta S
    J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S1-3. PubMed ID: 20387105
    [No Abstract]   [Full Text] [Related]  

  • 19. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.
    Lazarus AH
    J Clin Immunol; 2010 May; 30 Suppl 1():S20-3. PubMed ID: 20401687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases.
    Yu Z; Lennon VA
    N Engl J Med; 1999 Jan; 340(3):227-8. PubMed ID: 9895405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.